Novo A/S

This is the limited version of the Novo A/S company profile: Join LinkedIn or Sign In to see more information.

Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.

Novo A/S is a major shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.

Novo A/S’ objective is to manage the Foundation’s financial assets through investments in the life science area and in a broad portfolio of financial assets.

Specialties

Venture Capital, Growth Equity, Financial management, Seed financing

Your Connections to Novo A/S

To see how you’re connected: Join Now or Sign In

New Hires and Recent Promotions at Novo A/S

René Schneider, Vice President

was Director - 3 months ago
Anna Duus Vedsoe, Corporat Vice President

was Vice President - 3 months ago
Claus Steensen Sølje (Soelje), Vice President - Diabetes API Support Management

was Director - Finance, Logistic, IT & Administration - 4 months ago
Michael Møllmann, Corporate Vice President

was Corporate Vice President - 4 months ago
Anneline Nansen, Principal scientist

was Research scientist - last month

To see more new hires & promotions: Join Now or Sign In

Jobs at Novo A/S

Job Title	Location	Hiring Manager
HRT Global Medical Advisor	Zürich Area, Switzerland	To see who posted this job and how you’re connected: Join LinkedIn or Sign In

See all 1 jobs »

Last edited by SAP Senior Business Analyst at Novo Nordisk

Top Locations

Novo A/S Headquarters Address

Novo A/S Krogshoejvej 41
Bagsvaerd, - 2880
Denmark
Phone: +45 8824 8824
Fax: 45 44 49 05 55

Headquarters	Copenhagen Area, Denmark
Industry	Pharmaceuticals
Type	Privately Held
Status	Operating
Company Size	28,500 employees
2006 Revenue	38,743 mil [DKK] (15%)
Founded	1989
Website	http://www.novo.dk

More Novo A/S info »

Common Job Titles

Diabetes Care Specialist	5%
Project Manager	4%
Manager	4%
Chemist	4%
Scientist	4%

Top Schools

Danmarks Tekniske Universitet	11%
Københavns Universitet	9%
Copenhagen Bus. School	6%
Danmarks Farmaceutiske Universitet	6%
Handelshøjskolen i København	5%

Median Age	32 years

Gender

Male	52%
Female	48%

Estimated based on LinkedIn Data

Subsidiaries

Career path for Novo A/S employees

before:

In partnership with

This LinkedIn Company Profile was created by LinkedIn and is about Novo A/S. This page is not endorsed by or affiliated with Novo A/S. For questions regarding LinkedIn Company Profiles, contact us.

Novo A/S (NOVO B) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions

Companies

Novo A/S var dbl_url = "http://ad.doubleclick.net/adj/linkedin.dart/"; var dbl_src = dbl_url + "company_public_profile;optout=false;lang=en;;tile=1;sz=91x28;" + encodeURIComponent('company=2229') + ";ord=161412410?"; document.write('<script src="' + dbl_src + '" type="text/javascript"><\/script>');

Specialties

Your Connections to Novo A/S

New Hires and Recent Promotions at Novo A/S

René Schneider, Vice President

Anna Duus Vedsoe, Corporat Vice President

Claus Steensen Sølje (Soelje), Vice President - Diabetes API Support Management

Michael Møllmann, Corporate Vice President

Anneline Nansen, Principal scientist

Jobs at Novo A/S

Key Statistics about Novo A/S

Top Locations

Novo A/S Headquarters Address

Companies related to Novo A/S

Subsidiaries

Career path for Novo A/S employees

before:

after:

News

Novo A/S Blog

EFSD/Novo Nordisk partnership for diabetes research in Europe

Novo Nordisk extends programme of free insulin and diabetes care to reach 700 children in Bangladesh

News about Novo A/S

Novo Nordisk maintains more than 50 percent of the insulin market by volume around the world, thanks to its focused strategy. The Denmark-based company said that it will continue this approach in China, which is its fastest-growing market.

Stock Information about Novo A/S